STOCK TITAN

Lifevantage Corp Financials

LFVN
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE June

This page shows Lifevantage Corp (LFVN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LFVN FY2025

LifeVantage’s model is a high-gross-margin business where profit recovery depends more on SG&A absorption than heavy reinvestment.

Versus the prior year, net income rose to $9.8M while operating cash flow stayed near $11.9M, so the earnings rebound was real but not fully cash-released. The likely absorber was inventory build: inventory expanded from $15.1M to $20.7M, meaning more of the recovery was parked in working capital than collected immediately.

The key operating change happened below gross profit, not at the product level: gross margin held around 80.4% while operating margin recovered to 5.3%, which points to better absorption of selling and administrative costs rather than a reset in product economics.

This remains a cash-generative, low-capex model: free cash flow reached $10.5M with only $1.4M of capital spending, so maintaining the business appears to require relatively little reinvestment. Liquidity also looks workable, with a current ratio of 1.9x and cash of $20.2M, helping explain how the company funded payouts while still supporting operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 45 / 100
Financial Profile 45/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Lifevantage Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
30

Lifevantage Corp has an operating margin of 5.3%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is up from 2.2% the prior year.

Growth
39

Lifevantage Corp's revenue grew 14.2% year-over-year to $228.5M, a solid pace of expansion. This earns a growth score of 39/100.

Leverage
80

Lifevantage Corp carries a low D/E ratio of 1.08, meaning only $1.08 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 80/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
33

Lifevantage Corp's current ratio of 1.87 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
35

Lifevantage Corp has a free cash flow margin of 4.6%, earning a moderate score of 35/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
53

Lifevantage Corp's ROE of 28.3% shows moderate profitability relative to equity, earning a score of 53/100. This is up from 11.3% the prior year.

Altman Z-Score Safe
3.66

Lifevantage Corp scores 3.66, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong
7/9

Lifevantage Corp passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.21x

For every $1 of reported earnings, Lifevantage Corp generates $1.21 in operating cash flow ($11.9M OCF vs $9.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$228.5M
YoY+14.2%
5Y CAGR-0.4%
10Y CAGR+1.8%

Lifevantage Corp generated $228.5M in revenue in fiscal year 2025. This represents an increase of 14.2% from the prior year.

EBITDA
$15.4M
YoY+94.0%
5Y CAGR-3.4%
10Y CAGR-0.5%

Lifevantage Corp's EBITDA was $15.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 94.0% from the prior year.

Net Income
$9.8M
YoY+233.8%
5Y CAGR-3.2%
10Y CAGR+3.2%

Lifevantage Corp reported $9.8M in net income in fiscal year 2025. This represents an increase of 233.8% from the prior year.

EPS (Diluted)
$0.75
YoY+226.1%
5Y CAGR-1.0%
10Y CAGR+4.1%

Lifevantage Corp earned $0.75 per diluted share (EPS) in fiscal year 2025. This represents an increase of 226.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$10.5M
YoY+5.6%
5Y CAGR-7.7%
10Y CAGR-1.4%

Lifevantage Corp generated $10.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 5.6% from the prior year.

Cash & Debt
$20.2M
YoY+19.6%
5Y CAGR-1.8%
10Y CAGR+3.8%

Lifevantage Corp held $20.2M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.17
YoY-69.7%

Lifevantage Corp paid $0.17 per share in dividends in fiscal year 2025. This represents a decrease of 69.7% from the prior year.

Shares Outstanding
12M
YoY-0.6%
5Y CAGR-2.8%
10Y CAGR-1.2%

Lifevantage Corp had 12M shares outstanding in fiscal year 2025. This represents a decrease of 0.6% from the prior year.

Margins & Returns

Gross Margin
80.4%
YoY+1.1pp
5Y CAGR-3.3pp
10Y CAGR-4.9pp

Lifevantage Corp's gross margin was 80.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.1 percentage points from the prior year.

Operating Margin
5.3%
YoY+3.2pp
5Y CAGR-1.3pp
10Y CAGR-2.0pp

Lifevantage Corp's operating margin was 5.3% in fiscal year 2025, reflecting core business profitability. This is up 3.2 percentage points from the prior year.

Net Margin
4.3%
YoY+2.8pp
5Y CAGR-0.7pp
10Y CAGR+0.5pp

Lifevantage Corp's net profit margin was 4.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.8 percentage points from the prior year.

Return on Equity
28.3%
YoY+17.0pp
5Y CAGR-6.4pp
10Y CAGR-366.2pp

Lifevantage Corp's ROE was 28.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 17.0 percentage points from the prior year.

Capital Allocation

R&D Spending
$1.4M
YoY+100.0%
5Y CAGR+9.2%
10Y CAGR-5.2%

Lifevantage Corp invested $1.4M in research and development in fiscal year 2025. This represents an increase of 100.0% from the prior year.

Share Buybacks
$3.1M
YoY-51.1%
5Y CAGR-10.3%
10Y CAGR-10.8%

Lifevantage Corp spent $3.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 51.1% from the prior year.

Capital Expenditures
$1.4M
YoY-38.9%
5Y CAGR-12.6%
10Y CAGR+1.7%

Lifevantage Corp invested $1.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 38.9% from the prior year.

LFVN Income Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Revenue $43.7M-10.7% $48.9M+2.9% $47.6M-13.7% $55.1M-5.7% $58.4M-13.8% $67.8M+43.5% $47.2M-3.5% $48.9M
Cost of Revenue $9.2M-27.9% $12.7M+30.5% $9.7M-11.9% $11.1M-0.4% $11.1M-15.8% $13.2M+39.0% $9.5M-5.3% $10.0M
Gross Profit $34.5M-4.6% $36.2M-4.2% $37.8M-14.2% $44.0M-6.9% $47.3M-13.3% $54.6M+44.7% $37.7M-3.0% $38.9M
R&D Expenses $200K0.0% $200K-33.3% $300K-40.0% $500K+25.0% $400K+100.0% $200K-33.3% $300K+50.0% $200K
SG&A Expenses $13.9M-12.4% $15.8M+6.6% $14.9M-20.5% $18.7M+9.5% $17.1M-8.3% $18.6M+25.4% $14.8M+5.9% $14.0M
Operating Income $1.7M+244.6% $487K-78.5% $2.3M+5.6% $2.1M-47.0% $4.1M+18.2% $3.4M+33.4% $2.6M-11.7% $2.9M
Interest Expense $11K N/A N/A N/A N/A N/A N/A -$782K
Income Tax $294K+49.2% $197K+129.1% $86K-80.3% $437K-38.5% $710K+31.7% $539K-28.3% $752K-46.6% $1.4M
Net Income $1.4M+393.5% $276K-87.2% $2.2M+10.0% $2.0M-43.5% $3.5M+36.1% $2.5M+39.6% $1.8M+39.9% $1.3M
EPS (Diluted) $0.11+450.0% $0.02-88.2% $0.17 N/A $0.26+36.8% $0.19+35.7% $0.14 N/A

LFVN Balance Sheet

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Total Assets $62.1M+1.6% $61.2M-0.7% $61.6M-14.4% $72.0M-6.8% $77.2M+12.7% $68.5M+11.5% $61.5M+1.9% $60.3M
Current Assets $39.3M+2.0% $38.6M-14.4% $45.0M-11.5% $50.9M-6.0% $54.1M+18.2% $45.8M+18.0% $38.8M+3.1% $37.6M
Cash & Equivalents $12.5M+22.6% $10.2M-22.2% $13.1M-35.2% $20.2M-10.1% $22.5M+4.0% $21.6M+48.0% $14.6M-13.6% $16.9M
Inventory $18.4M-3.1% $19.0M-7.8% $20.6M-0.4% $20.7M-7.0% $22.2M+27.2% $17.5M+3.3% $16.9M+12.3% $15.1M
Accounts Receivable $2.4M+7.3% $2.3M-7.0% $2.4M-26.4% $3.3M+1.7% $3.2M+55.2% $2.1M-29.7% $3.0M+0.6% $2.9M
Goodwill $472K0.0% $472K N/A $0 N/A N/A N/A N/A
Total Liabilities $28.8M+2.2% $28.2M-0.8% $28.4M-23.8% $37.3M-13.7% $43.2M+11.9% $38.6M+14.4% $33.8M-1.6% $34.3M
Current Liabilities $20.1M+5.7% $19.0M+1.0% $18.8M-30.8% $27.2M-16.5% $32.6M+18.3% $27.5M+24.8% $22.1M-1.1% $22.3M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $33.3M+1.1% $33.0M-0.5% $33.2M-4.3% $34.6M+1.9% $34.0M+13.8% $29.9M+7.9% $27.7M+6.6% $26.0M
Retained Earnings -$103.7M-0.2% -$103.4M-0.3% -$103.1M+1.0% -$104.1M-0.6% -$103.5M+2.8% -$106.5M+1.9% -$108.5M+0.2% -$108.7M

LFVN Cash Flow Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Operating Cash Flow $5.0M+78.7% $2.8M+221.1% -$2.3M-322.9% $1.0M-53.6% $2.2M-75.8% $9.2M+1677.9% -$583K-122.6% $2.6M
Capital Expenditures $1.0M-6.7% $1.1M+146.9% $439K+120.6% $199K-39.9% $331K-32.7% $492K+41.0% $349K+25.5% $278K
Free Cash Flow $4.0M+133.0% $1.7M+162.2% -$2.7M-428.6% $835K-56.0% $1.9M-78.2% $8.7M+1034.2% -$932K-140.5% $2.3M
Investing Cash Flow -$1.0M+79.1% -$4.8M-999.5% -$439K-120.6% -$199K+39.9% -$331K+32.7% -$492K-42.6% -$345K-24.1% -$278K
Financing Cash Flow -$1.6M-116.5% -$738K+82.8% -$4.3M-32.5% -$3.2M-187.8% -$1.1M+19.5% -$1.4M+23.4% -$1.8M+33.3% -$2.7M
Dividends Paid $573K-0.3% $575K+0.7% $571K+1.6% $562K+11.7% $503K+0.2% $502K+0.4% $500K-0.6% $503K
Share Buybacks $1.0M+100700.0% -$1K-100.2% $578K-71.6% $2.0M $0 $0-100.0% $1.1M-39.2% $1.8M

LFVN Financial Ratios

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Gross Margin 79.0%+5.0pp 74.0%-5.5pp 79.5%-0.4pp 79.9%-1.1pp 81.0%+0.4pp 80.5%+0.6pp 79.9%+0.4pp 79.5%
Operating Margin 3.8%+2.8pp 1.0%-3.8pp 4.8%+0.9pp 3.9%-3.0pp 6.9%+1.9pp 5.1%-0.4pp 5.4%-0.5pp 5.9%
Net Margin 3.1%+2.6pp 0.6%-4.0pp 4.5%+1.0pp 3.5%-2.4pp 5.9%+2.2pp 3.8%-0.1pp 3.9%+1.2pp 2.7%
Return on Equity 4.1%+3.3pp 0.8%-5.7pp 6.5%+0.8pp 5.7%-4.5pp 10.2%+1.7pp 8.5%+1.9pp 6.6%+1.6pp 5.0%
Return on Assets 2.2%+1.7pp 0.4%-3.1pp 3.5%+0.8pp 2.7%-1.8pp 4.5%+0.8pp 3.7%+0.7pp 3.0%+0.8pp 2.2%
Current Ratio 1.96-0.1 2.03-0.4 2.39+0.5 1.87+0.2 1.660.0 1.66-0.1 1.76+0.1 1.69
Debt-to-Equity 0.860.0 0.850.0 0.86-0.2 1.08-0.2 1.27-0.0 1.29+0.1 1.22-0.1 1.32
FCF Margin 9.1%+5.6pp 3.5%+9.3pp -5.8%-7.3pp 1.5%-1.7pp 3.3%-9.6pp 12.8%+14.8pp -2.0%-6.7pp 4.7%

Similar Companies

Frequently Asked Questions

Lifevantage Corp (LFVN) reported $228.5M in total revenue for fiscal year 2025. This represents a 14.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Lifevantage Corp (LFVN) revenue grew by 14.2% year-over-year, from $200.2M to $228.5M in fiscal year 2025.

Yes, Lifevantage Corp (LFVN) reported a net income of $9.8M in fiscal year 2025, with a net profit margin of 4.3%.

Lifevantage Corp (LFVN) reported diluted earnings per share of $0.75 for fiscal year 2025. This represents a 226.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lifevantage Corp (LFVN) had EBITDA of $15.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Lifevantage Corp (LFVN) had a gross margin of 80.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Lifevantage Corp (LFVN) had an operating margin of 5.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Lifevantage Corp (LFVN) had a net profit margin of 4.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Lifevantage Corp (LFVN) paid $0.17 per share in dividends during fiscal year 2025.

Lifevantage Corp (LFVN) has a return on equity of 28.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Lifevantage Corp (LFVN) generated $10.5M in free cash flow during fiscal year 2025. This represents a 5.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Lifevantage Corp (LFVN) generated $11.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Lifevantage Corp (LFVN) had $72.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Lifevantage Corp (LFVN) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Lifevantage Corp (LFVN) invested $1.4M in research and development during fiscal year 2025.

Yes, Lifevantage Corp (LFVN) spent $3.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Lifevantage Corp (LFVN) had 12M shares outstanding as of fiscal year 2025.

Lifevantage Corp (LFVN) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.

Lifevantage Corp (LFVN) had a debt-to-equity ratio of 1.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Lifevantage Corp (LFVN) had a return on assets of 13.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Lifevantage Corp (LFVN) has an Altman Z-Score of 3.66, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Lifevantage Corp (LFVN) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Lifevantage Corp (LFVN) has an earnings quality ratio of 1.21x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Lifevantage Corp (LFVN) scores 45 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top